Resource Center
-
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
Black people and Native Americans are under-represented in Cancer Drug trials of new drugs
Black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at…
Read More » -
Study Discovers Link Between Electronic Cigarette Use and Bladder Cancer
March 29, 2021 By Christopher Brown Substances linked to bladder cancer found in the urine of e-cigarette users Recently published…
Read More » -
Updated NCCN Guideline Recommends Tivozanib Regimen in Clear Cell Renal Cell Carcinoma
Christoph Baker Mar 29 | 2021 National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib)…
Read More » -
Guidelines for Kidney Cancer Treatment
A list of global guidelines for kidney cancer are provided in this section. These guidelines provide evidence-based recommendations to serve as a guide…
Read More » -
Clinical Trials Resource Center
Are you interested in participating in a clinical trial? This page provides background information on clinical trials; access to listings…
Read More »
